DYN

Conviction 86HealthcareScan · Tue, Sep 8, 2026

Bullish belt hold

DYN$20.31-16.37%

ResistanceSupportVol 14Insider buyInsider sell

Vol MA14 1.91M

Jun 9Jun 26Jul 16Aug 3Aug 20Sep 8

Dyne Therapeutics, Inc.PHARMACEUTICAL PREPARATIONSwww.dyne-tx.com ↗

Price20.31

Change-16.37%

Gap-29.70%

Rel volume3.54×

Avg volume1.84M

Avg $ vol45.76M

SMA 2025.53

SMA 5024.75

SMA 20019.91

Price vs 50-17.95%

Price vs 200+1.96%

MA stackmixed

50/200 cross—

Supertrenddown · 23.73

RSI (14)23

MACD hist-0.57

MACD cross—

Stoch %K / %D33 / 18

ADX (14)19

+DI / −DI14 / 51

RSI divergence—

MACD divergence—

ATR %+7.13%

ADR %4.12%

52w high26.78

52w low12.37

From 52w high-24.18%

Above 52w low+64.15%

New 52w highNo

SqueezeOff

Bollinger width21.12%

%B-0.47

Donchian pos31.61%

Donchian high27.31

Donchian low17.07

AVWAP (52w high)24.68

vs AVWAP high-17.73%

AVWAP (52w low)19.73

vs AVWAP low+2.92%

OBV trendDown

Chaikin MF (20)0.09

Today vs 20d3.54×

Avg vol (14d)1.91M

Avg vol (20d)1.84M

Avg $ vol (20d)45.76M

Market cap—

RS 3m (vs SPY)+38.06%

RS 6m (vs SPY)+48.84%

RS line new highNo

Trend template7/8

Technical rank29.7

1 week-20.15%

1 month-22.65%

3 months+20.79%

6 months+14.78%

1 year+42.79%

YTD+9.76%

P/E-10.16

P/B6.46

P/S—

P/FCF-11.19

EPS-3.47

Div yield—

ROE-63.55%

ROA-44.89%

Debt/Eq0.01

Current12.02

EV/EBITDA-8.30

Gross margin—

Net margin—

Rev growth—

EPS growth-40.58%

Price target41.90

Target upside72.57%

Analyst ratingBuy

Institutional115.89%

Ent. value3.87B

Revenue—

Net income-178.56M

Gross profit—

Free cash flow-405.13M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out165.31M

Employees258

ListedThu, Sep 17, 2020

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeA+

Conviction86 / 100

Pattern quality—

Tech rank29.7 / 100

Group rank96 / 100 · Leading

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmBullish belt hold

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in DYN

All disclosures →

No recent disclosed trades by Congress in DYN. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in DYN · 10 sells

Insider	Side	Shares	Value	Traded	Filed
Rhodes Jason P Director · Common Stock · 2026-08-14	Sell	1.36M	$34M	2026-08-14	2026-08-17
Rhodes Jason P Director · Common Stock · 2026-08-14	Sell	478.38K	$12M	2026-08-14	2026-08-17
Rhodes Jason P Director · Common Stock · 2026-08-14	Sell	322.46K	$8.1M	2026-08-14	2026-08-17
Rhodes Jason P Director · Common Stock · 2026-08-13	Sell	63.64K	$1.7M	2026-08-13	2026-08-17
Lucera Erick Chief Financial Officer · Common Stock · 2026-08-13	Sell	1.8K	$47K	2026-08-13	2026-08-17
Kerr Douglas Chief Medical Officer · Common Stock · 2026-08-13	Sell	1.56K	$41K	2026-08-13	2026-08-17
Cox John CEO & President · Common Stock · 2026-08-13	Sell	4.99K	$131K	2026-08-13	2026-08-17
Friedl-Naderer Johanna Chief Commercial Officer · Common Stock · 2026-08-13	Sell	226	$6K	2026-08-13	2026-08-17
Rhodes Jason P Director · Common Stock · 2026-08-13	Sell	268.35K	$7.0M	2026-08-13	2026-08-17
Rhodes Jason P Director · Common Stock · 2026-08-13	Sell	94.42K	$2.5M	2026-08-13	2026-08-17

SEC filings

EDGAR filings in DYN · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.

DYN

Recent news

Get daily signals & real-time alerts.